Table 1.
Clinicopathological characteristics of patients undergoing liver transplantation for hepatocellular carcinoma.
| Variable | Without TACE (n=33) | With TACE (n=55) | p |
|---|---|---|---|
| Patient age (years) | |||
| ≤60 | 14 (42.4) | 23 (41.8) | 0.956 |
| >60 | 19 (57.6) | 32 (58.2) | |
| Gender | |||
| Male | 26 (78.8) | 47 (85.5) | 0.421 |
| Female | 7 (21.2) | 8 (14.5) | |
| Graft tumour recurrence | |||
| With | 5 (15.2) | 6 (10.9) | 0.560 |
| Without | 28 (84.8) | 49 (89.1) | |
| Distant metastases | |||
| With | 4 (12.1) | 9 (16.4) | 0.007 |
| Without | 29 (87.9) | 46 (83.6) | |
| Graft rejection | |||
| With | 16 (48.5) | 13 (23.6) | 0.016 |
| 6Without | 17 (51.5) | 42 (76.4) | |
| Tumour size (mm) | |||
| ≤20 | 19 (57.6) | 44 (80.0) | 0.030 |
| >20 | 14 (42.4) | 11 (20.0) | |
| Angioinvasion | |||
| Positive | 4 (12.1) | 6 (10.9) | 0.862 |
| Negative | 29 (87.9) | 49 (89.1) | |
| Lymphangiosis carcinomatosa | |||
| Positive | 1 (3.0) | 7 (12.7) | 0.126 |
| Negative | 32 (97.0) | 48 (87.3) | |
| Histologic differentiation | |||
| G1 well | 15 (45.5) | 29 (52.7) | 0.509 |
| G2 moderate/G3 poor | 18 (54.5) | 26 (47.3) | |
| Pathologic T stage | |||
| T1 | 28 (84.8) | 27 (49.1) | 0.001 |
| T2/T3 | 5 (15.2) | 28 (50.9) | |
| Alcoholic liver cirrhosis | |||
| With | 19 (57.6) | 40 (72.7) | 0.143 |
| Without | 14 (42.4) | 15 (27.3) | |
| Viral hepatitis | |||
| With | 10 (30.3) | 9 (16.4) | 0.124 |
| Without | 23 (69.7) | 46 (83.6) | |
| NASH | |||
| With | 2 (6.1) | 7 (12.7) | 0.318 |
| Without | 31 (93.9) | 48 (87.3) | |
| Hemochromatosis | |||
| With | 2 (6.1) | 0 (0.0) | 0.065 |
| Without | 31 (93.9) | 55 (100.0) | |